高级检索
当前位置: 首页 > 详情页

Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Urinary Surg, 1111 XianXia Rd, Shanghai 200336, Peoples R China [2]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Intervent Radiol, 1111 XianXia Rd, Shanghai 200336, Peoples R China
出处:
ISSN:

关键词: metastasis microenvironment signal transduction

摘要:
Circular RNA VANGL1 (circVANGL1) is generated from two exons of the Van Gogh-like 1 (VANGL1) gene and serves as a tumor promoter by sponging certain microRNAs (miRNAs). However, the role of circVANGL1 in bladder cancer (BC) is still unclear. So, in order to investigate the role of circVANGL1 in BC, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was employed to evaluate the circVANGL1 expression in tumor tissues from BC patients and in BC cell lines. Small interfering RNA against circVANGL1 was constructed and stably transfected into human bladder epithelium immortalized cells (SV-HUC). Cell invasion and migration were detected in Transwell chambers, cell proliferation was determined by CCK8 assays, and tumorigenesis in nude mice was examined to assess the effect of circVANGL1 in BC. Subcellular localization of circVANGL1 was confirmed by fluorescence in situ hybridization. The interactive relationships among circVANGL1, miRNA, and relative proteins were confirmed by luciferase reporter assays. The results showed that circVANGL1 was upregulated in both BC tissues and cell lines. Silencing the expression of circVANGL1 suppressed cell invasion, migration, and proliferation during in vitro experiments. Mechanistically, we demonstrated that circVANGL1 upregulated the expression of miR-1184 target gene insulin-like growth factor-binding protein 2 (IGFBP2) by sponging miR-1184, which promoted the aggressive biological behaviors of BC. Taken together, our results indicate that circVANGL1 acts as a tumor promoter through the novel circVANGL1/miR-1184/IGFBP2 axis. Hopefully, our study will provide new ideas for the clinical treatment of BC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Urinary Surg, 1111 XianXia Rd, Shanghai 200336, Peoples R China
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Urinary Surg, 1111 XianXia Rd, Shanghai 200336, Peoples R China [2]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Intervent Radiol, 1111 XianXia Rd, Shanghai 200336, Peoples R China [*1]Department of Interventional Radiology, Tongren Hospital, Shanghai Jiaotong University School of Medicine, 1111 XianXia Road, Shanghai 200336, China. [*2]Department of Urinary Surgery, Tongren Hospital, Shanghai Jiaotong University School of Medicine, 1111 XianXia Road, Shanghai 200336, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)